Align Technology, Inc. $ALGN Shares Acquired by Empowered Funds LLC

Empowered Funds LLC lifted its stake in shares of Align Technology, Inc. (NASDAQ:ALGN) by 3,811.7% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 50,500 shares of the medical equipment provider’s stock after buying an additional 49,209 shares during the quarter. Empowered Funds LLC’s holdings in Align Technology were worth $9,561,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Redmond Asset Management LLC grew its position in Align Technology by 2.0% in the first quarter. Redmond Asset Management LLC now owns 2,769 shares of the medical equipment provider’s stock valued at $440,000 after acquiring an additional 54 shares in the last quarter. Horizon Investments LLC boosted its stake in shares of Align Technology by 6.2% in the first quarter. Horizon Investments LLC now owns 1,018 shares of the medical equipment provider’s stock valued at $162,000 after purchasing an additional 59 shares during the period. Atria Investments Inc boosted its stake in shares of Align Technology by 4.9% in the second quarter. Atria Investments Inc now owns 1,575 shares of the medical equipment provider’s stock valued at $298,000 after purchasing an additional 74 shares during the period. IFP Advisors Inc grew its holdings in Align Technology by 5.7% during the 2nd quarter. IFP Advisors Inc now owns 1,427 shares of the medical equipment provider’s stock valued at $270,000 after purchasing an additional 77 shares in the last quarter. Finally, Covestor Ltd increased its stake in Align Technology by 18.8% during the 1st quarter. Covestor Ltd now owns 493 shares of the medical equipment provider’s stock worth $78,000 after buying an additional 78 shares during the period. Hedge funds and other institutional investors own 88.43% of the company’s stock.

Align Technology Stock Down 0.2%

NASDAQ:ALGN opened at $132.28 on Wednesday. The company has a market cap of $9.49 billion, a PE ratio of 25.64, a P/E/G ratio of 1.49 and a beta of 1.84. The business’s 50 day moving average is $132.75 and its two-hundred day moving average is $158.40. Align Technology, Inc. has a 52 week low of $122.00 and a 52 week high of $246.19.

Align Technology (NASDAQ:ALGN) last issued its quarterly earnings results on Wednesday, October 29th. The medical equipment provider reported $2.61 earnings per share for the quarter, beating analysts’ consensus estimates of $2.38 by $0.23. Align Technology had a return on equity of 14.06% and a net margin of 9.50%.The business had revenue of $995.69 million during the quarter, compared to the consensus estimate of $980.75 million. During the same period in the previous year, the business earned $2.35 EPS. The business’s quarterly revenue was up 1.8% on a year-over-year basis. Align Technology has set its Q4 2025 guidance at EPS. As a group, sell-side analysts expect that Align Technology, Inc. will post 7.98 EPS for the current fiscal year.

Align Technology declared that its board has approved a stock buyback plan on Tuesday, August 5th that allows the company to repurchase $200.00 million in shares. This repurchase authorization allows the medical equipment provider to repurchase up to 2% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s board believes its stock is undervalued.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on ALGN shares. Needham & Company LLC reissued a “hold” rating on shares of Align Technology in a research report on Thursday, October 30th. HSBC boosted their price target on Align Technology from $140.00 to $150.00 in a research note on Friday, October 31st. Stifel Nicolaus set a $200.00 price objective on Align Technology in a research note on Thursday, October 30th. Wall Street Zen raised Align Technology from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. Finally, Piper Sandler reiterated an “overweight” rating and set a $200.00 target price (up from $190.00) on shares of Align Technology in a research note on Thursday, October 30th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $175.45.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.